Wanbury Limited — Updates, 28-04-2026: Press Release

Wanbury's Patalganga site successfully passed Korea FDA (MFDS) inspection with zero observations, confirming cGMP compliance. This strengthens its regulatory track record, adding to prior USFDA and Anvisa approvals. A new API manufacturing block is also under validation.